Ofclav 1.2 inj - Astemax Biotech Ofclav 1.2 inj - Astemax Biotech

Ofclav 1.2 inj

Introduction

Ofclav-625 inj.

Ofclav Injection is a potent antibiotic combination of Amoxycillin, Potassium and Clavulanic Acid, designed for severe bacterial infections requiring intravenous administration.

Key Uses

Ofclav Injection treats a wide range of bacterial infections, including respiratory tract infections (like pneumonia and bronchitis), urinary tract infections, skin and soft tissue infections, ear/nose/throat infections (such as sinusitis and tonsillitis), bone/joint infections, and post-surgical infections. It is also effective for prophylaxis in surgeries involving the gastrointestinal tract, pelvic cavity, head/neck, or biliary tract to prevent bacterial complications.

Benefits

This injection provides rapid relief from severe infections by targeting resistant bacteria, often improving symptoms within a few days while preventing resistance development if the full course is completed. Its broad-spectrum action makes it suitable for hospital settings, helping patients recover faster from complicated cases like multidrug-resistant tuberculosis or abdominal infections.

How It Works

Amoxycillin, a penicillin antibiotic, kills bacteria by disrupting their cell wall formation, which is essential for bacterial survival. Clavulanic Acid enhances this by inhibiting beta-lactamase enzymes produced by resistant bacteria, protecting Amoxycillin and ensuring efficacy against a broader range of pathogens. Together, they overcome antibiotic resistance for comprehensive infection control

Get a Quote
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors